Company ProfilePremium

CHR-Hansen

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
CHR-Hansen - Food & Beverages showcase

Year Founded & Workforce

1874

3,151 Employees

Industry

Food & Beverages

Services

PROBIO-TECBIOPLUS YCGALLIPRO
C

CHR-Hansen Employee Contacts

5 verified contactsNames, job titles, seniority and locations

View Employee Contacts

CHR-Hansen Overview

Company Headquarters: Hørsholm, Denmark

Founded: 1874

Workforce: 3,151

Company Working: CHR-Hansen is a multinational company, which offers solutions to improve food and health. The company manufactures different products under five broad segments including food cultures and enzymes, natural colors, plant health, animal health, and probiotic supplements & infant formula. It offers probiotic strains, which are used in different areas such as gastrointestinal balance, immune system support, and women’s microflora. The company has production units located in Denmark, Germany, France, the Czech Republic, Brazil, China, Italy, Peru, and the US. The company caters to customers present globally.

Strategy

Chr. Hansen A/S is focused on R&D to develop new products, which will broaden its product portfolio. It strategizes to excel in the development of bioprotection, plant health and the human microbiome, which are its key strategic areas. The company aims to build long term strategic relations with its customers by providing customized solutions to cater to customer demand, at a lucrative cost-to-value ratio for customers. The company is planning to invest in marketing and distribution network to achieve market penetration.

Company Snapshot

$938M

Revenue

3,151

Employees

1874

Founded

Hørsholm, Denmark

Headquarters

SWOT Analysis

Strengths

  • Focus on R&D
  • Strong production facility

Weaknesses

  • Limited probiotic products range

Opportunities

  • Development of microbial strains, which have scientifically proven benefits

Threats

  • Intense competition

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
Nov-2016AcquisitionChr. Hansen acquired full ownership of the LGG strain from Valio Ltd. LGG strain is used in dietary supplements since 1990. The acquisition helped the company broaden its product portfolio.

Product Offering

  • CHR-Hansen
    • PROBIO-TEC
    • BIOPLUS YC
    • GALLIPRO

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: SBU breakup-0 rose from USD 938 Mn in 2015 to USD 1,255.2 Mn in 2018.
CHR-Hansen — By Business Segment
Series (USD Mn)2015201620172018
SBU breakup-0938999.71,272.71,255.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.